非氧化改性低密度脂蛋白:动脉样硬化的低估风险因素
Yimeng Zhao1, Qian Xu1, Naiqi He1
1Key Laboratory for Arteriosclerology of Hunan Province, Department of Cardiovascular Medicine, Institute of Cardiovascular Disease, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, The Third Affiliated Hospital, Hengyang Medical College, University of South China, Hengyang 421001, China.
Current medicinal chemistry
|August 8, 2023
概括
动脉样硬化是由不仅仅是氧化的LDL驱动的. 本综述强调了非氧化改性LDL.
科学领域:
- 心血管研究研究心血管研究
- 生物化学 生化学
- 病理学 病理学 病理学
背景情况:
- 动脉样硬化每年导致数百万人的死亡,主要与心血管疾病有关.
- 氧化低密度脂蛋白 (oxLDL) 是动脉样硬化发展的关键因素.
- 目前的抗氧化剂疗法在减少心血管疾病发病率和死亡率方面表现出有限的有效性.
研究的目的:
- 审查与动脉样硬化相关的非氧化改性低密度脂蛋白 (非oxLDL).
- 阐明非-oxLDL对动脉动脉产生有所贡献的途径和机制.
- 为了确定新的治疗策略和药物点对动脉样硬化心血管疾病.
主要方法:
- 对LDL修饰和动脉样硬化现有研究的文献综述.
- 对参与非oxLDL诱导的动脉样硬化的途径的分析.
- 讨论由非氧性LDL驱动的动脉动生成机制.
主要成果:
- 几种非氧化改性LDL亚型与动脉样硬化有关.
- 非oxLDL通过特定的分子途径启动和促进动脉样硬化.
- 了解非oxLDL机制为治疗提供了新的途径.
结论:
- 不氧化LDL的修饰在动脉样硬化中起着至关重要的作用.
- 专注于非oxLDL途径可能会产生比单独针对oxLDL更有效的治疗方法.
- 这一综述为开发针对动脉样硬化心血管疾病的新疗法提供了基础.
相关概念视频
Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Coronary Artery Disease IV: Preventive Measures
24
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
24
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Overview of Lipid Metabolism
1.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.8K


